Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acceso Biotech develops accessible point-of-care diagnostic solutions targeting global health needs. Their flagship products include the VITA™ point-of-care CD4 test—designed to address advanced HIV disease diagnosis in low/middle-income countries—and the Ecco™ imaging cytometer for cell analysis in research and cell therapy development. The VITA test requires minimal training, uses small blood samples, delivers results rapidly (<3 minutes), and aims to improve care access where laboratory infrastructure may be limited. The Ecco cytometer supports multi-color fluorescence-based cell analysis without lasers or sheath fluidics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acceso.